These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16783088)

  • 1. Histochemical and enzymehistochemical alterations during experimental cardiomyopathy.
    Kirvalidze I; Khetsuriani R; Jorbenadze T; Shukakidze A; Kipiani T
    Georgian Med News; 2006 May; (134):129-31. PubMed ID: 16783088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of essential phospholipids (EPL) on experimental cobalt-induced cardiomyopathy.
    Wójcicki J; Rózewicka L; Kadyków M
    Arzneimittelforschung; 1973 Aug; 23(8):1070-4. PubMed ID: 4358339
    [No Abstract]   [Full Text] [Related]  

  • 3. Etiopathogenesis of cardiomyopathies: a review.
    Kirvalidze I; Jorbenadze T; Khetsuriani R
    Georgian Med News; 2009 Sep; (174):104-8. PubMed ID: 19801746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histological, electron microscopic and biochemical study of the rat liver in experimental cardiomyopathy].
    Bykovskaia KN; Moshkov DA; Roze LV; Popova IA; Rozenfel'd EL
    Arkh Patol; 1981; 43(1):36-40. PubMed ID: 7011276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy.
    Ito T; Kimura Y; Uozumi Y; Takai M; Muraoka S; Matsuda T; Ueki K; Yoshiyama M; Ikawa M; Okabe M; Schaffer SW; Fujio Y; Azuma J
    J Mol Cell Cardiol; 2008 May; 44(5):927-37. PubMed ID: 18407290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histochemical, ultrastructural and structural changes in primary cardiomyopathy and in cobalt cardiomyopathy.
    Olsen EG
    Postgrad Med J; 1972 Dec; 48(566):760-2. PubMed ID: 4677116
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of physical overloads on the state of the cardiomyocytes in experimental autoimmune cardiomyopathy].
    Sharov VG; Bykovskaia KN; Saks VA
    Arkh Patol; 1979; 41(2):15-21. PubMed ID: 426643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ultrastructure of the myocardium in experimental autoimmune cardiomyopathy].
    Sharov VG; Vikhert AM
    Arkh Patol; 1976; 38(5):27-34. PubMed ID: 1023848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy.
    Westermann D; Van Linthout S; Dhayat S; Dhayat N; Schmidt A; Noutsias M; Song XY; Spillmann F; Riad A; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2007 Nov; 102(6):500-7. PubMed ID: 17909696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histochemical detection of tissue changes using tetrazolium salts of differing nitrosensitivity].
    Seidler E
    Acta Histochem; 1983; 73(2):219-25. PubMed ID: 6421067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total triterpene acids, active ingredients from Fructus Corni, attenuate diabetic cardiomyopathy by normalizing ET pathway and expression of FKBP12.6 and SERCA2a in streptozotocin-rats.
    Qi MY; Liu HR; Dai DZ; Li N; Dai Y
    J Pharm Pharmacol; 2008 Dec; 60(12):1687-94. PubMed ID: 19000375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental data on the mechanism of development of alcoholic cardiomyopathy].
    Tsyplenkova VG; Vikhert AM; Stepantsov VV
    Biull Eksp Biol Med; 1985 Sep; 100(9):367-70. PubMed ID: 4041613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pyrrolidine dithiocarbamate on antioxidant enzymes in cardiomyopathy induced by adriamycin in rats.
    Mingyan E; Hongli L; Shufeng L; Bo Y
    Cardiology; 2008; 111(2):119-25. PubMed ID: 18376123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of myophosphorylase in ethanol induced cardiomyopathy.
    Baruah JK; Kinder D
    Exp Pathol; 1988; 33(4):197-200. PubMed ID: 3229454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
    Niu YG; Evans RD
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental morphological study, using electron microscopy, of adriamycin-induced cardiomyopathy].
    Accardo G; Aleotti A; Pazzi A; Tampieri ML; Zennaro A; Casaro S
    G Clin Med; 1983; 64(1-2):1-11. PubMed ID: 6862137
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
    Van Linthout S; Seeland U; Riad A; Eckhardt O; Hohl M; Dhayat N; Richter U; Fischer JW; Böhm M; Pauschinger M; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2008 Jul; 103(4):319-27. PubMed ID: 18347835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracellular reorganization and ultrastructural stereologic analysis of cardiomyocytes from W/SSM rats with genetically determined cardiomyopathy].
    Lushnikova EL; Nepomniashchikh LM; Postnikova OA; Tsimmerman VG
    Biull Eksp Biol Med; 1999 Aug; 127(8):233-7. PubMed ID: 11188753
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of biophysical factors on the redox processes and biological oxidation. Changes in the succinate dehydrogenase activity after the application of ultrasound].
    Belewa-Staikowa R; Tschiftschiiski S; Dragiev M
    Radiobiol Radiother (Berl); 1970; 11(6):729-35. PubMed ID: 5509239
    [No Abstract]   [Full Text] [Related]  

  • 20. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.
    Xiang P; Deng HY; Li K; Huang GY; Chen Y; Tu L; Ng PC; Pong NH; Zhao H; Zhang L; Sung RY
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):343-9. PubMed ID: 18379782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.